CoChat

The CC chemokine antagonist Met‐RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3

Elsner, Jörn, Petering, Holger, Höchstetter, Renate, Kimmig, Daniela, Wells, Timothy N. C., Kapp, Alexander, Proudfoot, Amanda E. J. · 1997 · European Journal of Immunology
Cited by 127

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Eosinophils are predominant effector cells not only in allergic diseases but also in connective tissue diseases. The recruitment of eosinophils to the site of inflammation and release of reactive oxygen species leading to tissue damage and propagation of the inflammatory response are mediated by chemokines. Thus, agents that would be able to inhibit or antagonize chemokine‐induced eosinophil activation are interesting as therapeutical agents. We describe the effect of a chemokine receptor antagonist, Met‐RANTES, on human eosinophil effector functions in response to RANTES, monocyte chemoattractant protein (MCP)‐3 and eotaxin. Met‐RANTES was able to inhibit dose‐dependently [Ca 2+]i transients in eosinophils following stimulation with RANTES, MCP‐3 and eotaxin. Whereas maximal and half‐maximal inhibitory effect of Met‐RANTES following stimulation with RANTES and MCP‐3 were observed at 2 μg/ml and 1 μg/ml, respectively, maximal and half‐maximal inhibitory effects of Met‐RANTES in response to eotaxin were detected at 10 μg/ml and 3 μg/ml. Moreover, eotaxin‐induced [Ca 2+]i transients were only half reduced at a Met‐RANTES concentration at which RANTES and MCP‐3 were completely blocked. Besides its effect on [Ca 2+]i transients, Met‐RANTES dose‐dependently inhibited actin polymerization in eosinophils following chemokine stimulation. Whereas Met‐RANTES totally inhibited RANTES‐ and MCP‐3‐induced actin polymerization at 5 μg/ml, the eotaxin‐induced response was only reduced by 50%. However, Met‐RANTES inhibited dose‐dependently the release of reactive oxygen species in response to RANTES, MCP‐3 and eotaxin. Again, eotaxin‐induced release of reactive oxygen species, however, was only half reduced at a Met‐RANTES concentration (10 μg/ml) at which RANTES and MCP‐3 were completely blocked. The results of this study show that (1) Met‐RANTES is an effective and powerful antagonist of effector functions of human eosinophils following stimulation with RANTES, MCP‐3 and eotaxin; (2) Met‐RANTES seems to be able to antagonize the response of eosinophils through chemokine receptor 1 (CCR1) preferentially to CCR3; (3) Met‐RANTES antagonizes eosinophil but not neutrophil effector functions and might be therefore of interest for a new therapeutical approach to prevent the invasion and destructive power of eosinophils in diseases that are accompanied by eosinophil infiltration such as allergic asthma and connective tissue diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/eji.1830271122

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 127

Metadata

Authors
Elsner, J., Petering, H., Höchstetter, R., Kimmig, D., Wells, T. N. C., Kapp, A., & Proudfoot, A. E. J.
Venue
European Journal of Immunology
Publisher
Wiley
Published
1997-11
Volume
27
Issue
11
Pages
2892-2898
ISSN
  • 0014-2980 (ISSN-L)
  • 1521-4141
OpenAlex
W2050439545
Cited by
127
References
2
FWCI
4.44
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.